Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: 18 | Mind Blowing Facts

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.

Bangkok Post

Moderna sues Pfizer over patents behind COVID-19 vaccine

COVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech, accusing the rivals of copying Moderna’s technology in order to make their own vaccine

The Independent UK

Moderna sues Pfizer-BioNTech accusing them of copying Covid shot technology

‘We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,’ Moderna legal officer says

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna sues Pfizer, BioNTech over COVID-19 vaccine

The lawsuit seeks unspecified monetary damages for patent infringement.

Axios

Tweaked COVID boosters close but how much will they help?

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help

The Independent UK

Moderna Whale Trades For August 23

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 53 strange trades.

Benzinga

Pfizer files application for booster against latest variants

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Everything you need to know about the new Covid vaccine that targets omicron variant

o serious safety concerns have been identified for this new bivalent treatment

Wales Online

All over-50s to get a new Covid jab targeted to protect against Omicron variant

Britain became the first country to approve a “bivalent” jab on Monday that directly targets Omicron and the original Covid-19 strain - as 29 million people will initially be invited for the vaccine

Daily Mirror

‘No second-rate vaccines’ health chief insists as half will miss out on dual-strain booster

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available

The Independent UK

Who can get Covid booster as new Omicron jab that targets Omicron to be used

The new jab is bivalent, meaning it protects against the original Covid strain as well as the Omicron variant

Daily Record

The U.K. approved omicron-specific booster shots. They're coming to the U.S. soon

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

WEKU

Full details of next Covid booster rollout -and Omicron jab will be used

The Government has confirmed who will get another Covid injection and says new vaccine will be used

Wales Online

The UK Approved A Combo Vaccine To Protect Against Omicron Variants Pls Givvus That One Next

Moderna's bivalent vaccine is seen as the "next step" in COVID protection.

Pedestrian.tv

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

The Canberra Times

Labor doubles down on domestic manufacturing

The prime minister has made claims Australia must be more self-reliant.

AAP

Australian virus cases close to 10 million

The total number of COVID-19 cases identified in Australia since the start of the pandemic is closing in on 10 million.

Evening Standard

Moderna vaccine: how the new Covid bivalent Omicron jab works

An Omicron-specific booster vaccination has been approved in the UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart

Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.

Evening Standard

First Covid-19 jab to target two strains included in autumn booster programme

Adults over 50 and clinically vulnerable people will be offered the first Covid-19 jab to target two strains of the virus, as part of the UK’s autumn booster programme.

The Independent UK

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

Edinburgh Live

Who can get a Covid vaccine booster in the UK?

The autumn booster program for Covid vaccinations will begin shortly. Over 50s, carers, frontline health workers and those at clinical risk will be inited to get a booster jab.

Benzinga

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Independent UK

Covid: New dual-strain booster vaccine targeting Omicron to be rolled out in autumn

UK first country to approve use of so-called bivalent vaccine as officials prepare for winter and expected rise in Covid cases

The Guardian - UK

Dual-variant Covid vaccine approved for UK booster programme

Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.